303 related articles for article (PubMed ID: 33675123)
1. PRMT5 promotes colorectal cancer growth by interaction with MCM7.
Li X; Wang X; Zhao J; Wang J; Wu J
J Cell Mol Med; 2021 Apr; 25(7):3537-3547. PubMed ID: 33675123
[TBL] [Abstract][Full Text] [Related]
2. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
3. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
4. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression.
Demetriadou C; Pavlou D; Mpekris F; Achilleos C; Stylianopoulos T; Zaravinos A; Papageorgis P; Kirmizis A
Cell Death Dis; 2019 Mar; 10(3):236. PubMed ID: 30858358
[TBL] [Abstract][Full Text] [Related]
5. PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
Hartley AV; Wang B; Mundade R; Jiang G; Sun M; Wei H; Sun S; Liu Y; Lu T
Sci Rep; 2020 Sep; 10(1):15934. PubMed ID: 32985589
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.
Ge S; Zhang Q; Chen Y; Tian Y; Yang R; Chen X; Li F; Zhang B
Toxicol Appl Pharmacol; 2021 Mar; 415():115450. PubMed ID: 33577917
[TBL] [Abstract][Full Text] [Related]
7. miR-107 regulates the effect of MCM7 on the proliferation and apoptosis of colorectal cancer via the PAK2 pathway.
Zhao M; Wang Y; Jiang C; Wang Q; Mi J; Zhang Y; Zuo L; Geng Z; Song X; Ge S; Li J; Wen H; Wang J; Wang Z; Su F
Biochem Pharmacol; 2021 Aug; 190():114610. PubMed ID: 34010598
[TBL] [Abstract][Full Text] [Related]
8. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades.
Yan Y; Zhao P; Wang Z; Liu Z; Wang Z; Zhang J; Ding Y; Hua X; Yu L
Aging (Albany NY); 2021 Jan; 13(3):4468-4481. PubMed ID: 33495409
[TBL] [Abstract][Full Text] [Related]
9. Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer.
Hartley AV; Wang B; Jiang G; Wei H; Sun M; Prabhu L; Martin M; Safa A; Sun S; Liu Y; Lu T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456215
[TBL] [Abstract][Full Text] [Related]
10. Cell metabolic profiling of colorectal cancer via
Ge S; Zhang Q; Tian Y; Hao L; Duan J; Zhang B
Clin Chim Acta; 2020 Nov; 510():291-297. PubMed ID: 32707041
[TBL] [Abstract][Full Text] [Related]
11. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
[TBL] [Abstract][Full Text] [Related]
12. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer.
Toyokawa G; Masuda K; Daigo Y; Cho HS; Yoshimatsu M; Takawa M; Hayami S; Maejima K; Chino M; Field HI; Neal DE; Tsuchiya E; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
Mol Cancer; 2011 May; 10():65. PubMed ID: 21619671
[TBL] [Abstract][Full Text] [Related]
14. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy.
Abumustafa W; Castven D; Becker D; Salih SS; Manzoor S; Zamer BA; Talaat I; Hamad M; Marquardt JU; Muhammad JS
Cell Signal; 2024 Jul; 119():111166. PubMed ID: 38588876
[TBL] [Abstract][Full Text] [Related]
16. PRMT6 functionally associates with PRMT5 to promote colorectal cancer progression through epigenetically repressing the expression of CDKN2B and CCNG1.
Chen Y; Liang W; Du J; Ma J; Liang R; Tao M
Exp Cell Res; 2023 Jan; 422(1):113413. PubMed ID: 36400182
[TBL] [Abstract][Full Text] [Related]
17. Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers.
Prabhu L; Wei H; Chen L; Demir Ö; Sandusky G; Sun E; Wang J; Mo J; Zeng L; Fishel M; Safa A; Amaro R; Korc M; Zhang ZY; Lu T
Oncotarget; 2017 Jun; 8(25):39963-39977. PubMed ID: 28591716
[TBL] [Abstract][Full Text] [Related]
18. Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies.
Abumustafa W; Zamer BA; Khalil BA; Hamad M; Maghazachi AA; Muhammad JS
Biomed Pharmacother; 2022 Jan; 145():112368. PubMed ID: 34794114
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma.
Xia T; Liu M; Zhao Q; Ouyang J; Xu P; Chen B
Cell Death Dis; 2021 Sep; 12(10):851. PubMed ID: 34531375
[TBL] [Abstract][Full Text] [Related]
20. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X
Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
